ecancer

IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients with BRAFV600 mutation-positive advanced melanoma

Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia

1 May 2020

Continuous vs intermittent dosing of dabrafenib and trametinib in BRAF mutated melanoma

Prof Alain Algazi -University of California San Francisco, San Francisco, USA

30 Apr 2020

Where have we got to with cancer treatment?

Prof Alexander Eggermont - Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands

27 Jan 2020

The treatment landscape of occular melanoma

Maitry Patel CCPA - Princess Margaret Cancer Centre, Toronto, Canada

21 Oct 2019

CheckMate 067: Nivolumab plus ipilimumab combination therapy in advanced melanoma

Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain

7 Oct 2019

IMspire170: New combination treatment for advanced melanoma

Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain

7 Oct 2019

Melanoma highlights from ESMO 2019

Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany

30 Sep 2019

Implementing national cancer control plans

Dr Eduardo Cazap and Dr Lisa Stevens

24 Jun 2019

Latest updates in melanoma research

Dr Alexander van Akkooi - The Netherlands Cancer Institute, Amsterdam, Netherlands

21 Mar 2019

Education and innovation in surgical oncology

Prof Riccardo Audisio - Sahlgrenska University Hospital, Göteborg, Sweden

23 Jan 2019

The Central Malignant Melanoma Registry in Germany

Prof Ulrike Leiter-Stöppke - University of Tübingen, Tübingen, Germany

23 Nov 2018

Melanoma incidence: signs for a decline?

Prof David Whiteman - QIMR Berghofer Medical Research Institute, Brisbane, Australia

22 Nov 2018

More from ecancer